Campuses

As France's leading biocluster, Genopole is an incubator for cutting-edge projects in biotechnology. Located in the city of Évry, just south of Paris, Genopole provides a unique environment for scientists and entrepreneurs seeking to advance research and innovation.

Discover >

Advantages

Genopole accompanies researchers, postdocs and start-up entrepreneurs through all the phases of their projects to ensure the best possible conditions for business development.

Discover >

Genopole’s citizens

Every day, at Genopole, researchers, entrepreneurs and students cross paths, share ideas and unite forces in a veritable melting pot for innovation.

Discover >

Highlights

Giving wings to research and empowering employment in our community are cornerstones of Genopole's mission. Catch up on recent scientific advances, the accomplishments of our biotech actors and the events that enliven the biocluster.

Discover >

Innovate with us

Discover >
Highlights

Very-high-selectivity mass spectrometry


The citizens of Genopole and the Paris-Saclay campus now have access to an essential technology for biotech.
Spectrométrie de masse à très haute spécificité - de la plateforme Spectrométrie de masse à très haute spécificité - de la plateforme

The mass spectrometry platform, accredited by Genopole and operated by the Laboratory for Analysis and Modeling in Biology and the Environment (LAMBE) (University of Évry/CNRS/Cergy Paris University) shas acquired a Select Series Cyclic IMS system, an instrument with an unmatched ability to separate, characterize and quantify molecular species in complex samples. It attains that level of performance through a combination of high resolution capacities and cyclic ion mobility technology.
Financed by Genopole and theUniversity of Évry Paris-Saclay, the system was installed in June 2023 at LAMBE, the personnel of which contribute expertise in analytical chemistry, structural analysis and biophysics to its deployment. This mass spectrometry system, one of only three available in France, is mutualized by Genopole to respond to the biotech research and innovation needs of the site’s labs and businesses.

Indeed, the growth of post-genomics and its application in health, biomaterials, energy, nonfood crops and the environment is creating a growing need for high-sensitivity, high-resolution molecular characterization among not only academic laboratories but also industrial entities.
The SELECT SERIES Cyclic IMS (see image) responds to these challenges in research and innovation. It brings a disruptive technology, cyclic ion mobility (cIM) separation, to the detection and structural characterization of molecules in mixed samples via mass spectrometry (MS). This particularly versatile, state of the art instrument will meet the R&D demands of the academic laboratories and biotech businesses at the Évry biocluster and Paris-Saclay University. It is already serving the needs of five biocluster labs (SABNP, LBEPS, Genomics Metabolics, GenHotel and LAMBE:
(SABNP, LBEPS, Genomics Metabolics, GenHotel, LAMBE).

A remarkably complete range of technologies at the platform

LAMBE has a wide range of ion sources and fragmentation modalities to serve the new MS system. Such sources as ESI, nanoESI, ASAP, APCI, and DESI enable analyses of liquids and solids. Particularly, DESI enables analyses via molecular imaging. Different fragmentation modalities, that is, methods used to break chemical bonds (by CID, ECD or SID), can also diversify the obtained structural information. This is the case for certain proteins, peptides and oligo/polysaccharides that contain labile groups, and for large supramolecular assemblies.

CitationIn terms of performance, thanks to its time of flight (ToF) analyzer equipped with two electrostatic mirrors, this new instrument can attain very high resolution values, for example greater than 100,000 (M/ΔM) for the [M+6H]6+ ion of bovine insulin” explains Régis Daniel, director of LAMBE in charge of the mass spectrometry platform. “The high-resolution capacity enables the separation of a greater number of molecular species and eases structural determination” he continues. “The system provides compound mass measurement to a precision of <0.5 ppm, which permits the determination of the empirical formulae of small molecules with greater confidence“.

The cIM system’s separation dimension can also be supplemented with upstream coupling to either analytical/micro-flow (ACQUITY Premier) or nanoflow (ACQUITY UPLC M-Class) liquid chromatography.

Mass spectrometry teamed with cyclic ion mobility: a disruptive technology

Recent technological developments have led to the marketing of novel instruments with ever-increasing resolution power. in 2019, as a part of those advances, the company Waters introduced the SELECT SERIES Cyclic IMS, a quadrupole Tof (QToF) mass spectrometer teamed with a high-resolution ion mobility technology.
This disruptive technology involves a circular, gas-filled ion mobility cell that drives ions to do multiple revolutions within it. This allows for the measurement of the mobility of the ions in the gas and in turn their separation according to their three-dimensional structures.
The number of revolutions possible in the mobility cell is theoretically unlimited and thus the ions’ trajectories too. This results in unequaled separation performance (ultra-high mobility resolution up to about 750, compared to a maximum of 250 in older systems).

That ion mobility separation is coupled to the mass spectrometer within the same SELECT SERIES Cyclic IMS instrument, which constitutes a very powerful pair for discriminating different compounds sharing a same mass, or differently organized compounds sharing a same composition. Combining the above with upstream chromatographic separation gives one of the most powerful analytical systems the world has to offer.

To conclude


With this rare piece of technology associated with LAMBE’s expertise, the mass spectrometry platform opens new vistas for Genopole’s researchers and entrepreneurs and more largely for the South Île-de-France scientific community. This includes perspectives in molecular biology for a better understanding of living processes, in the search for compounds of interest in medicine or the environment, or in the industrial development of innovative biomaterials” underlines Julien Picot, platforms manager at Genopole.

  • The platform offer: a Genopole specificity

    Genopole provides access to 24 shared-use technological platforms for its businesses and laboratories.
    Its objective is to provide these entities with concrete solutions across all biotech-associated fields of research: cellular biology and imaging, molecular biology, structural biology, bioproduction, biological resources, functional testing, bioinformatics and robotics & automation.

    Counting collectively more than 600 shared-use devices, some of which represent the cutting-edge of technology, Genopole’s platforms are key enablers of success, empowering novel discoveries for the biocluster’s academic labs and confirmation of the potential of innovations forwarded by its companies.

  • More on research at LAMBE

    The Laboratory for Analysis and Modeling in Biology and the Environment (LAMBE) (LAMBE) develops analytical methods based on mass spectrometry (MS) and other technologies.
    Those novel methods are aimed at identifying relations between the structure and physicochemical properties of a compound under study (biomolecules, peptides, proteins, oligo/polysaccharides, polymers, etc.), understanding the underlying mechanism of action and analyzing biomolecular interactions.
    LAMBE seeks to:

    • overcome analytical obstacles (large and flexible molecular assemblies resistant to conventional biostructural methods, sulfoproteomics, interaction analyses, glycosaminoglycans structures and functions),
    • and establish novel structural data via innovative pairings of technologies (CE-MS, SPR-MS, IMS-MS), and new ionization (photoionization, ASAP, etc.) and activation (IRMPD, ETD, CTD) methods.

    To reach those goals, the laboratory benefits from seven mass spectrometers and access to national-level technological entities such as the free-electron laser CLIO and the national synchrotron facility (synchrotron SOLEIL).

Share
With the support from
Région île de France